Natural Alternatives International (NAII) Competitors $3.28 -0.03 (-0.91%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NAII vs. CRVO, CRBP, TCRX, IMAB, JMAC, INZY, CRBU, ADAP, GNTA, and XCURShould you be buying Natural Alternatives International stock or one of its competitors? The main competitors of Natural Alternatives International include CervoMed (CRVO), Corbus Pharmaceuticals (CRBP), TScan Therapeutics (TCRX), I-Mab (IMAB), Maxpro Capital Acquisition (JMAC), Inozyme Pharma (INZY), Caribou Biosciences (CRBU), Adaptimmune Therapeutics (ADAP), Genenta Science (GNTA), and Exicure (XCUR). These companies are all part of the "pharmaceutical products" industry. Natural Alternatives International vs. CervoMed Corbus Pharmaceuticals TScan Therapeutics I-Mab Maxpro Capital Acquisition Inozyme Pharma Caribou Biosciences Adaptimmune Therapeutics Genenta Science Exicure Natural Alternatives International (NASDAQ:NAII) and CervoMed (NASDAQ:CRVO) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment. Which has preferable valuation and earnings, NAII or CRVO? CervoMed has lower revenue, but higher earnings than Natural Alternatives International. CervoMed is trading at a lower price-to-earnings ratio than Natural Alternatives International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatural Alternatives International$121.85M0.17-$7.22M-$1.39-2.36CervoMed$7.14M10.70-$2.17M-$2.18-4.03 Does the MarketBeat Community favor NAII or CRVO? Natural Alternatives International received 254 more outperform votes than CervoMed when rated by MarketBeat users. However, 83.33% of users gave CervoMed an outperform vote while only 77.07% of users gave Natural Alternatives International an outperform vote. CompanyUnderperformOutperformNatural Alternatives InternationalOutperform Votes27977.07% Underperform Votes8322.93% CervoMedOutperform Votes2583.33% Underperform Votes516.67% Do insiders and institutionals hold more shares of NAII or CRVO? 32.4% of Natural Alternatives International shares are owned by institutional investors. Comparatively, 25.1% of CervoMed shares are owned by institutional investors. 20.9% of Natural Alternatives International shares are owned by company insiders. Comparatively, 35.4% of CervoMed shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has more volatility & risk, NAII or CRVO? Natural Alternatives International has a beta of 0.59, indicating that its stock price is 41% less volatile than the S&P 500. Comparatively, CervoMed has a beta of -0.23, indicating that its stock price is 123% less volatile than the S&P 500. Does the media prefer NAII or CRVO? In the previous week, CervoMed had 10 more articles in the media than Natural Alternatives International. MarketBeat recorded 16 mentions for CervoMed and 6 mentions for Natural Alternatives International. Natural Alternatives International's average media sentiment score of 0.32 beat CervoMed's score of 0.22 indicating that Natural Alternatives International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natural Alternatives International 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral CervoMed 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Is NAII or CRVO more profitable? Natural Alternatives International has a net margin of -6.26% compared to CervoMed's net margin of -118.68%. Natural Alternatives International's return on equity of -9.36% beat CervoMed's return on equity.Company Net Margins Return on Equity Return on Assets Natural Alternatives International-6.26% -9.36% -4.82% CervoMed -118.68%-44.11%-39.81% Do analysts rate NAII or CRVO? CervoMed has a consensus target price of $27.63, indicating a potential upside of 214.64%. Given CervoMed's stronger consensus rating and higher probable upside, analysts clearly believe CervoMed is more favorable than Natural Alternatives International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natural Alternatives International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00CervoMed 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 2 Strong Buy rating(s) 2.89 SummaryNatural Alternatives International beats CervoMed on 10 of the 19 factors compared between the two stocks. Get Natural Alternatives International News Delivered to You Automatically Sign up to receive the latest news and ratings for NAII and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAII vs. The Competition Export to ExcelMetricNatural Alternatives InternationalMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$20.33M$1.16B$5.43B$8.48BDividend YieldN/AN/A5.22%4.11%P/E Ratio-2.5410.5526.7920.05Price / Sales0.178.44394.72116.44Price / CashN/A10.4038.2534.62Price / Book0.261.466.864.61Net Income-$7.22M-$54.34M$3.22B$248.19M7 Day Performance1.55%2.72%6.83%2.97%1 Month Performance25.67%11.88%13.73%16.58%1 Year Performance-50.00%-38.30%18.22%8.16% Natural Alternatives International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAIINatural Alternatives International0.7228 of 5 stars$3.28-0.9%N/A-50.0%$20.33M$121.85M-2.54290News CoveragePositive NewsEarnings ReportAnalyst ForecastCRVOCervoMed3.3747 of 5 stars$9.10+7.2%$27.63+203.6%-55.5%$79.20M$7.14M-4.484CRBPCorbus Pharmaceuticals4.6266 of 5 stars$7.16+11.0%$50.88+610.5%-84.4%$78.93MN/A-1.5340Positive NewsTCRXTScan Therapeutics3.5295 of 5 stars$1.37+7.9%$8.50+520.4%-86.8%$77.53M$4.42M-1.29100Positive NewsIMABI-Mab3.2583 of 5 stars$0.95+7.4%$5.50+482.0%-47.9%$77.02M$3.27M0.00380News CoveragePositive NewsJMACMaxpro Capital AcquisitionN/A$5.68flatN/A+1,604.0%$76.27MN/A0.002,021Gap UpINZYInozyme Pharma2.9365 of 5 stars$1.18+2.6%$14.63+1,139.4%-16.5%$76.18MN/A-0.7650Earnings ReportCRBUCaribou Biosciences2.9713 of 5 stars$0.82+5.7%$9.33+1,040.9%-64.9%$76.09M$9.99M-0.50100ADAPAdaptimmune Therapeutics2.789 of 5 stars$0.30+0.9%$1.83+519.9%-73.9%$75.94M$178.03M-1.34490Gap UpGNTAGenenta Science1.5212 of 5 stars$4.13-5.0%$25.00+506.1%+43.4%$75.45MN/A0.007Gap DownXCURExicure1.4821 of 5 stars$11.86+3.7%N/A+2,046.5%$74.93M$500,000.00-5.7350 Related Companies and Tools Related Companies CervoMed Competitors Corbus Pharmaceuticals Competitors TScan Therapeutics Competitors I-Mab Competitors Maxpro Capital Acquisition Competitors Inozyme Pharma Competitors Caribou Biosciences Competitors Adaptimmune Therapeutics Competitors Genenta Science Competitors Exicure Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAII) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natural Alternatives International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natural Alternatives International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NAII Stock Free NAII Stock Alerts